Allergan heads to FDA with drug-device combo; Teleflex posts 8.2% revenue growth;

 @FierceMedDev: Experts: Taiwan, Israel should form med device alliance. Item | Follow @FierceMedDev

 @MarkHFierce: Today's DxExtra: LipoScience is moving head with development of a cardiovascular Dx that relies on gut flora. More | Follow @MarkHFierce

 @DamianFierce: HeartWare's sales leapt 87% in Q1 thanks to a successful U.S. ventricular pump launch. Article | Follow @DamianFierce

> Allergan ($AGN) is seeking FDA approval for Juvéderm Voluma, a facial recontouring drug-device combo, and the company will make its case to the agency's General and Plastic Surgery Devices Panel on Friday. More

> Teleflex ($TFX) posted $411.9 million in revenue last quarter, an 8.2% increase over the prior year, and the company expects full-year growth between 11% and 13%. Results

> Hospitals are using robotic medical devices that can kill superbugs with ultraviolet light or hydrogen peroxide vapors. Story

> Federal prosecutors are investigating devicemaker Cardiovascular Systems ($CSII) over possible insider trading, The Wall Street Journal reports. The company said it is complying with the government and has done nothing wrong. Article

> SQI Diagnostics is looking to raise $3.7 million through private placement. News

> Pittsburgh-based Jawbone acquired wearable medical device company BodyMedia for an undisclosed sum. Report

> The U.S. Preventive Services Task Force is recommending all Americans between 15 and 65 be screened for HIV, a move that could increase demand for tests from companies like OraSure ($OSUR) and Roche ($RHHBY). Item

Biotech News

 @FierceBiotech: From Brain atrophy could predict multiple sclerosis, study finds. More | Follow @FierceBiotech

 @JohnCFierce: Henri Termeer is joining the board at Moderna (big pact with AstraZeneca). Moderna gets my vote for fast co. status. I hope they pull it off. | Follow @JohnCFierce

 @RyanMFierce: Sanofi teams with BigData outfit NextBio to research drugs for diabetes and cancer. More | Follow @RyanMFierce

> Biotech upstart joins Big Pharma cast on high-profile 'breakthrough' stage. Item

> Aveo shares plunge after FDA review raises fears of tivozanib rejection. Story

> Regado gambles on $75M IPO to pay pricey PhIII tab. News

Pharma News

 @FiercePharma: Pfizer stock down on Q1 shortfall, lowered profits forecast. Sales down 9% to $13.5B. EPS expected at up to $2.24 now, down from $2.30. Results statement | Follow @FiercePharma

 @EricPFierce: Novartis to expanded Swiss OTC plant while taking ax to its troubled consumer facility in Lincoln, NE. Article | Follow @EricPFierce

> Pfizer cuts forecast as Q1 sales fall $550M short of estimates. News

> Regeneron execs score $140M payday as Eylea mints money. Article

> Merck wins bellwether Fosamax femur-fracture trial. More

Biotech Research News

 @EmilyMFierce: Investigators explore inflammation's role in Parkinson's development. Article | Follow @EmilyMFierce

> Malaria parasite protein could be used to prevent disease transmission. Item

> Gilead drug clears hep B virus in chimpanzees. More

> Zoonotic virus kills human melanoma cells in animal model. Story

> Harvard scientists discover hormone that could treat diabetes. Article

Pharma Manufacturing News

> FDA uncovers foreign-made Botox disguised as U.S. product. News

> Alexion brings in hired guns for troubled plant. Article

> Lonza API plant problems undermine Ipsen's Increlex supplies. More

> Blocking a gene's activity could clear beta-amyloid plaques in Alzheimer's. Story


Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.